NeuroSense Therapeutics Ltd

NAS:NRSNHealthcarenasdaq_composite

$2.44−4.69%At closeAt close · Fri 23 Oct · ≈ AED 8.96 · Market cap $4.63M · Next earnings Wed 2 Dec

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Return on equity	−429.1%	−44.9%	−219.6%	574.6%	−395.3%	713.1%	713.1%	+0.0 pts
Return on assets	−363.0%	−35.4%	−160.1%	−317.3%	−223.2%	−1,082.2%	−1,082.2%	+0.0 pts
Return on capital employed	−438.2%	−51.6%	−226.5%	4,397.4%	−383.4%	745.0%	—	—
Debt / equity	0.0×	0.0×	0.0×	−0.1×	0.0×	−0.1×	−0.1×	+0.0%
Debt / assets	0.0%	0.0%	2.7%	4.5%	1.6%	16.5%	—	—
Interest coverage	0.0×	−4.8×	−903.5×	−21.9×	−31.8×	0.0×	—	—
Current ratio	6.1×	19.1×	4.3×	0.8×	2.2×	0.3×	0.3×	+0.0%
Quick ratio	6.1×	19.4×	4.3×	0.8×	2.2×	0.3×	—	—
Cash ratio	5.8×	18.5×	2.1×	0.8×	1.7×	0.1×	0.1×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Inventory turnover	0.0×	0.0×	—	—	—	—	—	—
Receivables turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.